Horizon Therapeutics Public Limited Company

(HZNP) Trade

By |

Profile

Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.

Contact Information

Website: www.horizonpharma.com
Email: investor-relations@horizonpharma.com
Main Phone: +353 17722100
Address: 1 Burlington Road
Address 2: Connaught House, 1st Floor
City / Town: Dublin 4
Country: IE
Postal Code: D04 C5Y6

Issuer Information

Exchange: NGS
CEO: Timothy P. Walbert
Employees: 1225
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.

Contact Information

Website: www.horizonpharma.com
Email: investor-relations@horizonpharma.com
Main Phone: +353 17722100
Address: 1 Burlington Road
Address 2: Connaught House, 1st Floor
City / Town: Dublin 4
Country: IE
Postal Code: D04 C5Y6

Issuer Information

Exchange: NGS
CEO: Timothy P. Walbert
Employees: 1225
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 77.44 $ 1.38 (1.81%)
Last Price 77.44 Change $ 1.38 Change % 1.81 Tick N/A
Bid 76.11 Bid Size 1,000.00 Ask 78.83 Ask Size 100.00
Open 75.94 High 78.04 Low 75.94 Prev Close 76.06
Last Trade Volume 2 mi 52 Wk Hi 86.67 52 Wk Low 23.81
Market Cap 17.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 220,346,699.00 EPS (TTM) 2.61 PE Ratio 29.70 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 36 64
Number of Buys 18 32
Number of Sells 18 32
Net Activity 242822 343770
Last 10 Buys Shares
Michael G. Grey 1,000
H. Thomas Watkins 1,000
H. Thomas Watkins 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Last 10 Sell Shares
Brian K. Beeler 1,000
Brian K. Beeler 1,000
Timothy P. Walbert 1,000
Brian K. Beeler 1,000
Robert F. Carey 1,000
Robert F. Carey 1,000
Jeffrey W. Sherman 1,000
Virinder Nohria 1,000
Jeffrey W. Sherman 1,000
Jeffrey W. Sherman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 24 24 24 24
Low Target Price Estimate 16 16 16 16
Mean Target Price Estimate 20 20 20 20
Standard Deviation 3.21 3.21 3.21 3.21
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1.29 1.29